A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
The presence of P+PBac{XP5.WH5}BSC855 was verified using the PCR methods and primers described in FBrf0175003.
The breakpoints of Df(2L)BSC855 predicted from the Release 5 genomic coordinates of the insertion sites of the progenitor transposable elements P{XP}d05987 and PBac{WH}CG9426f05662 are 2L:12832803 ;13219548 and the cytological breakpoints predicted from these coordinates are 34A1;34A10.